US Patent Issued to The Johns Hopkins University on Feb. 24 for "Genomic alterations in the tumor and circulation of pancreatic cancer patients" (Maryland Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,802, issued on Feb. 24, was assigned to The Johns Hopkins University (Baltimore).

"Genomic alterations in the tumor and circulation of pancreatic cancer patients" was invented by Victor Velculescu (Dayton, Md.), Mark Sausen (Baltimore), Vilmos Adleff (Baltimore) and Jillian Phallen (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pancreatic adenocarcinoma has the worst overall mortality of any solid tumor, with only 7% of patients surviving after 5 years. To evaluate the clinical implications of genomic alterations in this low cellularity tumor type, we deeply sequenced the genomes of 101 enriched pancreatic adenocarcinomas from patients wh...